Acetyl-L-Carnitine · Neurology, Geriatrics, Metabolic disorders Acetyl-L-Carnitine facilitates the transport of long-chain fatty acids into mitochondria for β-oxidation, enhancing cellular energy production.
Cytotec (reference drug) · Gastroenterology Cytotec (misoprostol) is a prostaglandin E1 analog that reduces gastric acid secretion and protects the gastric mucosa.
Jublia® · Dermatology / Infectious Disease Jublia is a topical antifungal that inhibits fungal squalene epoxidase, disrupting ergosterol synthesis in the fungal cell membrane.
Motilitone® and Pantoline® · Gastroenterology Motilitone enhances gastric muscle contractions and accelerates gastric emptying by acting as a dopamine antagonist and acetylcholinesterase inhibitor.
Stillen Tab. · Gastroenterology Stillen is a digestive enzyme preparation that aids in the breakdown and absorption of nutrients in the gastrointestinal tract.
Phase 3 pipeline
DA-2802 · Women's Health / Endocrinology DA-2802 is a selective activator of estrogen receptor beta (ERβ) that modulates estrogen signaling to treat menopausal symptoms and potentially other hormone-related conditions.
DA-3002 · Oncology DA-3002 is a selective estrogen receptor degrader (SERD) that binds to and degrades estrogen receptors, eliminating both ligand-dependent and ligand-independent signaling in hormone receptor-positive breast cancer.
DA-3801 Injection · Endocrinology DA-3801 is a recombinant human growth hormone analog designed to promote growth and metabolic effects.
DA-5212 · Cardiovascular / Regenerative Medicine DA-5212 is a selective inhibitor of phosphodiesterase 5 (PDE5) that enhances nitric oxide signaling to improve blood flow and tissue perfusion.
DA-5212-R · Neurology; Psychiatry DA-5212-R is a small molecule that modulates dopamine and serotonin pathways to treat cognitive and neuropsychiatric symptoms.
DA-5219 · Gastroenterology DA-5219 is a selective serotonin 5-HT4 receptor partial agonist that enhances gastric motility and accelerates gastric emptying.
DA-6034 · Cardiovascular / Metabolic DA-6034 is a selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ) that enhances lipid metabolism and reduces inflammation.
DA5221-B1 DA5221-B1 is a therapeutic candidate in phase 3 development by Dong-A ST Co., Ltd., but its specific mechanism of action is not publicly disclosed.
DA5221-B2 · Endocrinology DA5221-B2 is a dual GLP-1/GIP receptor agonist that activates both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors to improve glycemic control and promote weight loss.
DA5221-T1 DA5221-T1 is a therapeutic agent in phase 3 development by Dong-A ST Co., Ltd., but its specific mechanism of action is not publicly disclosed.
DA5221-T2 · Endocrinology DA5221-T2 is a dual GLP-1/GIP receptor agonist that activates both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors to improve glycemic control and promote weight loss.
DMB-3115 · Neurology/Psychiatry DMB-3115 is a selective inhibitor of phosphodiesterase 10A (PDE10A) that increases intracellular cyclic nucleotide levels in the brain.
EPORON · Hematology/Oncology EPORON is an erythropoietin (EPO) receptor agonist that stimulates red blood cell production to treat anemia.
Leucostim 5µg/kg/day · Oncology, Hematology, Immunology Leucostim is a granulocyte colony-stimulating factor (G-CSF) that stimulates the proliferation and differentiation of neutrophil precursor cells in bone marrow.
Neupogen 5µg/kg/day · Oncology, Hematology, Immunology Neupogen (filgrastim) stimulates the bone marrow to produce and release neutrophils, increasing white blood cell counts to prevent or treat infections in immunocompromised patients.
Phase 2 pipeline
DA-1229 · Diabetes DA-1229 is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases levels of incretin hormones to improve blood glucose control in type 2 diabetes.